We are live on
!
Find out more
MA
Marshwinds Advisory Portfolio holdings
AUM
$187M
1-Year Est. Return
1.79%
This Fund
S&P 500
This Quarter
Est. Return
+6.69%
1 Year Est. Return
-1.79%
3 Year Est. Return
+32.92%
5 Year Est. Return
+52.83%
10 Year Est. Return
–
AUM
$215M
AUM Growth
+$5.13M
(+2.4%)
Cap. Flow
-$6.22M
Cap. Flow
% of AUM
-2.89%
Top 10 Holdings %
Top 10 Hldgs %
24.81%
Holding
142
New
3
Increased
18
Reduced
89
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.56M |
| 2 |
AbbVie
ABBV
|
+$368K |
| 3 |
ExxonMobil
XOM
|
+$283K |
| 4 |
AGN
Allergan Inc
AGN
|
+$213K |
| 5 |
Baxter International
BAX
|
+$207K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$3.29M |
| 2 |
Chemours
CC
|
+$728K |
| 3 |
T
A T & T CORP (NEW)
T
|
+$520K |
| 4 |
Johnson Controls International
JCI
|
+$419K |
| 5 |
Home Depot
HD
|
+$262K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.24% |
| 2 | Consumer Staples | 16.12% |
| 3 | Technology | 16.06% |
| 4 | Healthcare | 15.65% |
| 5 | Materials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Coca-Cola
KO
$377B
| $7M | 3.25% |
164,828
+870
| +0.5% | +$36.3K |
|
|
2
Chemours
CC
$2.49B
| $5.81M | 2.7% |
150,839
-24,182
| -14% | -$728K |
|
|
T
3
DELISTED
A T & T CORP (NEW)
T
| $5.68M | 2.64% |
136,764
-12,519
| -8% | -$520K |
|
4
Microsoft
MSFT
$3.44T
| $5.5M | 2.56% |
83,507
-488
| -0.6% | -$31.3K |
|
5
GE Aerospace
GE
$375B
| $5.41M | 2.51% |
37,860
-59
| -0.2% | -$8.54K |
|
6
Oracle
ORCL
$371B
| $5.21M | 2.42% |
116,851
-1,150
| -1% | -$47.9K |
|
7
Mondelez International
MDLZ
$79.6B
| $4.98M | 2.32% |
115,603
-646
| -0.6% | -$28.6K |
|
|
DD
8
DELISTED
Du Pont De Nemours E I
DD
| $4.76M | 2.21% |
59,294
-2,323
| -4% | -$180K |
|
9
Amgen
AMGN
$208B
| $4.56M | 2.12% |
27,767
+26
| +0.1% | +$4.32K |
|
10
Southern Company
SO
$109B
| $4.45M | 2.07% |
89,422
-1,022
| -1% | -$50.5K |
|
11
IBM
IBM
$209B
| $4.41M | 2.05% |
26,459
-304
| -1% | -$51K |
|
12
Pfizer
PFE
$143B
| $4.36M | 2.03% |
134,190
-150
| -0.1% | -$4.73K |
|
|
13
ExxonMobil
XOM
$641B
| $4.24M | 1.97% |
51,667
+3,384
| +7% | +$283K |
|
14
Merck
MRK
$322B
| $4.23M | 1.97% |
69,751
-1,211
| -2% | -$73.5K |
|
15
Procter & Gamble
PG
$335B
| $4.15M | 1.93% |
46,143
-1,149
| -2% | -$102K |
|
16
3M
MMM
$90.8B
| $3.96M | 1.84% |
24,737
+121
| +0.5% | +$18.6K |
|
17
Cisco
CSCO
$457B
| $3.83M | 1.78% |
113,198
-4,025
| -3% | -$131K |
|
18
Emerson Electric
EMR
$84.3B
| $3.81M | 1.77% |
63,685
+171
| +0.3% | +$10.2K |
|
19
Kraft Heinz
KHC
$30.8B
| $3.75M | 1.74% |
41,299
-341
| -0.8% | -$30.7K |
|
20
Northrop Grumman
NOC
$77.2B
| $3.6M | 1.67% |
15,140
-75
| -0.5% | -$17.8K |
|
21
Intel
INTC
$468B
| $3.54M | 1.64% |
98,028
-2,619
| -3% | -$94.8K |
|
22
Eli Lilly
LLY
$1.02T
| $3.52M | 1.64% |
41,820
-323
| -0.8% | -$25.9K |
|
|
RTN
23
DELISTED
Raytheon Company
RTN
| $3.29M | 1.53% |
21,578
-99
| -0.5% | -$14.9K |
|
24
Intuit
INTU
$86.5B
| $3.21M | 1.49% |
27,642
-339
| -1% | -$40.6K |
|
25
Tootsie Roll Industries
TR
$2.95B
| $3.08M | 1.43% |
107,746
-2,051
| -2% | -$58.8K |
|
Similar funds
GIM
WA
PCM
WAM
MBA
CC
KA
PPC
Marshwinds Advisory's Q1 2017 Portfolio in Review
As of Q1 2017, Marshwinds Advisory held 142 positions worth $215M, up 2.4% from $210M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Marshwinds Advisory's Q1 2017 filing shows 3 new, 18 increased, 89 reduced and 6 closed positions. Its largest new stake was Allergan Inc: 892 shares worth $213K. The largest sale was St Jude Medical, an estimated $3.29M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Technology.
- Marshwinds Advisory's largest Q1 2017 buy was Allergan Inc: 892 shares worth $213K.
- Marshwinds Advisory added most to Abbott in Q1 2017, an estimated $1.56M increase.
- Marshwinds Advisory's biggest Q1 2017 reduction was Chemours, cutting an estimated $728K.
- Marshwinds Advisory fully exited St Jude Medical in Q1 2017, selling an estimated $3.29M.
- Marshwinds Advisory's ten largest holdings make up 25% of its $215M portfolio in Q1 2017.
- Marshwinds Advisory opened 3 new positions and closed 6 in Q1 2017.
- Marshwinds Advisory's portfolio value rose 2.4% quarter-over-quarter to $215M.
Based on Marshwinds Advisory's 13F filing for Q1 2017, filed 12 Apr 2017.